215 related articles for article (PubMed ID: 20547842)
1. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.
Farias EF; Petrie K; Leibovitch B; Murtagh J; Chornet MB; Schenk T; Zelent A; Waxman S
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11811-6. PubMed ID: 20547842
[TBL] [Abstract][Full Text] [Related]
2. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells.
Dahiya NR; Leibovitch BA; Kadamb R; Bansal N; Waxman S
Cells; 2022 Mar; 11(7):. PubMed ID: 35406744
[TBL] [Abstract][Full Text] [Related]
3. Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
Kwon YJ; Petrie K; Leibovitch BA; Zeng L; Mezei M; Howell L; Gil V; Christova R; Bansal N; Yang S; Sharma R; Ariztia EV; Frankum J; Brough R; Sbirkov Y; Ashworth A; Lord CJ; Zelent A; Farias E; Zhou MM; Waxman S
Mol Cancer Ther; 2015 Aug; 14(8):1824-36. PubMed ID: 26078298
[TBL] [Abstract][Full Text] [Related]
4. Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer.
Bansal N; Bosch A; Leibovitch B; Pereira L; Cubedo E; Yu J; Pierzchalski K; Jones JW; Fishel M; Kane M; Zelent A; Waxman S; Farias E
Oncotarget; 2016 Jul; 7(28):43689-43702. PubMed ID: 27286261
[TBL] [Abstract][Full Text] [Related]
5. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract][Full Text] [Related]
6. Structural Insight into the Binding of TGIF1 to SIN3A PAH2 Domain through a C-Terminal Amphipathic Helix.
He X; Nie Y; Zhou H; Hu R; Li Y; He T; Zhu J; Yang Y; Liu M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884456
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the Mad1-mSin3A repressor-corepressor interaction reveals determinants of specificity, affinity, and transcriptional response.
Cowley SM; Kang RS; Frangioni JV; Yada JJ; DeGrand AM; Radhakrishnan I; Eisenman RN
Mol Cell Biol; 2004 Apr; 24(7):2698-709. PubMed ID: 15024060
[TBL] [Abstract][Full Text] [Related]
8. Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.
Bansal N; Petrie K; Christova R; Chung CY; Leibovitch BA; Howell L; Gil V; Sbirkov Y; Lee E; Wexler J; Ariztia EV; Sharma R; Zhu J; Bernstein E; Zhou MM; Zelent A; Farias E; Waxman S
Oncotarget; 2015 Oct; 6(33):34087-105. PubMed ID: 26460951
[TBL] [Abstract][Full Text] [Related]
9. Mad proteins contain a dominant transcription repression domain.
Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
[TBL] [Abstract][Full Text] [Related]
10. Conserved themes in target recognition by the PAH1 and PAH2 domains of the Sin3 transcriptional corepressor.
Sahu SC; Swanson KA; Kang RS; Huang K; Brubaker K; Ratcliff K; Radhakrishnan I
J Mol Biol; 2008 Feb; 375(5):1444-56. PubMed ID: 18089292
[TBL] [Abstract][Full Text] [Related]
11. A 13-amino acid amphipathic alpha-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A.
Eilers AL; Billin AN; Liu J; Ayer DE
J Biol Chem; 1999 Nov; 274(46):32750-6. PubMed ID: 10551834
[TBL] [Abstract][Full Text] [Related]
12. Pf1, a novel PHD zinc finger protein that links the TLE corepressor to the mSin3A-histone deacetylase complex.
Yochum GS; Ayer DE
Mol Cell Biol; 2001 Jul; 21(13):4110-8. PubMed ID: 11390640
[TBL] [Abstract][Full Text] [Related]
13. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
Hurst DR; Xie Y; Vaidya KS; Mehta A; Moore BP; Accavitti-Loper MA; Samant RS; Saxena R; Silveira AC; Welch DR
J Biol Chem; 2008 Mar; 283(12):7438-44. PubMed ID: 18211900
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of the mSin3A PAH2-Pf1 SID1 complex: a Mad1/Mxd1-like interaction disrupted by MRG15 in the Rpd3S/Sin3S complex.
Kumar GS; Xie T; Zhang Y; Radhakrishnan I
J Mol Biol; 2011 May; 408(5):987-1000. PubMed ID: 21440557
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complex.
Brubaker K; Cowley SM; Huang K; Loo L; Yochum GS; Ayer DE; Eisenman RN; Radhakrishnan I
Cell; 2000 Nov; 103(4):655-65. PubMed ID: 11106735
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners.
Le Guezennec X; Vermeulen M; Stunnenberg HG
Nucleic Acids Res; 2006; 34(14):3929-37. PubMed ID: 16914451
[TBL] [Abstract][Full Text] [Related]
17. Differential binding of Sin3 interacting repressor domains to the PAH2 domain of Sin3A.
Pang YP; Kumar GA; Zhang JS; Urrutia R
FEBS Lett; 2003 Jul; 548(1-3):108-12. PubMed ID: 12885416
[TBL] [Abstract][Full Text] [Related]
18. Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain.
Chandru A; Bate N; Vuister GW; Cowley SM
Sci Rep; 2018 Oct; 8(1):14689. PubMed ID: 30279502
[TBL] [Abstract][Full Text] [Related]
19. Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells.
Kwon YJ; Leibovitch BA; Bansal N; Pereira L; Chung CY; Ariztia EV; Zelent A; Farias EF; Waxman S
Oncotarget; 2017 Oct; 8(51):88421-88436. PubMed ID: 29179446
[TBL] [Abstract][Full Text] [Related]
20. Coupled unfolding and dimerization by the PAH2 domain of the mammalian Sin3A corepressor.
Zhang Y; Zhang Z; Demeler B; Radhakrishnan I
J Mol Biol; 2006 Jun; 360(1):7-14. PubMed ID: 16813833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
